Property and Casualty Insurance

Assurant

Eislan Q1 2026 Earnings: Record Global Lifestyle Revenue, EBITDA and EPS Rise

BMO and Morgan Stanley Raise Elevance Health Price Targets to $274-$285, Maintain Buy Ratings

Assurant released FY2026 Q1 earnings on May 5 After-Market EST, actual revenue USD 3.42 B (forecast USD 3.31 B), actual EPS USD 5.4099 (forecast USD 5.0666)

Assurant to Release FY2026 Q1 Earnings on May 5 After-Market EST, Forecast Revenue USD 3.31 B, EPS USD 5.3356

Eslan Announces 2025 Fiscal Year Financial Results and Outlines Future Profit Growth Outlook

Assurant released FY2025 earnings on February 10 After-Market EST, actual revenue USD 12.81 B (forecast USD 12.74 B), actual EPS USD 16.93 (forecast USD 17.9911)

Assurant released FY2025 Q4 earnings on February 10 After-Market EST, actual revenue USD 3.35 B (forecast USD 3.277 B), actual EPS USD 4.5471 (forecast USD 5.4309)

Assurant to Release FY2025 Q4 Earnings on February 10 After-Market (EST), Forecast Revenue USD 3.277 B, EPS USD 5.2832

Esland Acquires RL Circular Operations to Enhance Post-Purchase Services in Asia Pacific

JPMorgan Cuts Stake in Ascena

Aslan Company Returns Record Amounts in Q3 Through Mobile Trade-In Program

Esland's Board Approves $70 Million Stock Repurchase and a 10% Increase in Common Stock Dividends

Assurant released FY2025 9 Months Earnings on November 4 After-Market EST, actual revenue USD 9.464 B, actual EPS USD 12.5599

Assurant released FY2025 Q3 earnings on November 4 After-Market (EST), actual revenue USD 3.232 B (forecast USD 3.154 B), actual EPS USD 5.1699 (forecast USD 4.358)

Islan reports Q3 net income of $265.6 million and EPS of $5.17

Assurant to Release FY2025 Q3 Earnings on November 4 After-Market EST, Forecast Revenue USD 3.151 B, EPS USD 3.9716

Esland Acquires OptoFidelity's Technology to Enhance Device Refurbishment and Resale Capabilities

Esland and Evident Launch Risk Management Solution for Commercial Equipment Leasing Industry

Aslan Announces Completion of Senior Notes Public Offering

AIZ Reports Strong Q2 Earnings

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Assurant, Inc. (AIZ.US) Third Quarter 2025 Earnings Conference

Assurant, Inc. (AIZ.US) 2024 Fourth Quarter Earnings Conference

Assurant (NYSE:AIZ) shares reached a new 52-week high of $259.28, closing at $258.2750. Analysts have raised price targets, with Piper Sandler at $268, UBS at $274, and Truist at $290. The company reported Q1 earnings of $5.95 per share, exceeding estimates, with revenue of $3.42 billion. Insider selling activity was noted, and institutional investors have increased their stakes significantly.

Market Beat

Piper Sandler Cos

UBS Group AG

Truist Financial

Morgan Stanley

Bank of NY Mellon

Assurant Pref Share AIZN 5.25 01/15/61

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

BANK OF NEW YORK MELLON CORP DEP SHS REPG 1/4000TH INT SER K PFD

Assurant (NYSE:AIZ) Sets New 12-Month High  - Should You Buy?

Assurant, Inc. (NYSE:AIZ) has received a consensus rating of 'Moderate Buy' from ten research firms, with one hold and nine buy ratings. The average target price is $272.17. Morgan Stanley upgraded the stock to 'Overweight' with a target of $285, while UBS and Piper Sandler also raised their price targets. Assurant reported $5.95 EPS for Q1, exceeding estimates, with revenue of $3.42 billion, up 11.3% year-over-year.

Bank of Montreal

Assurant, Inc. (NYSE:AIZ) Receives Average Rating of "Moderate Buy" from Brokerages

Assurant (AIZ) reported Q1 revenue of $3.42 billion and net income of $274.1 million, with ongoing share repurchases. The stock has returned 11.8% in the past month and 27.8% over the past year. Analysts set a price target of $260, indicating the stock is 2.1% undervalued. However, its current P/E of 12.7x is above the industry average, suggesting caution regarding growth assumptions. Investors are encouraged to assess the company's potential and risks before making decisions.

Simplywall

A Look At Assurant (AIZ) Valuation After Strong Q1 Results And AI‑Supported Growth

Analyst Charlie Lederer from BMO Capital has raised the price target for Assurant to $274, maintaining a Buy rating. He cites the company's resilient growth, strong device care operations, and AI-driven efficiencies as key factors. Assurant is positioned well against traditional insurers and has opportunities for expansion in international markets. Morgan Stanley also upgraded the stock to a Buy with a $285 target.

- BMO Capital analyst Charlie Lederer maintains a buy rating on Assurant, raising the target price to $274.00.  
- Lederer cites Assurant's resilient growth characteristics, its differentiated positioning in insurance, and benefits from automation and AI-driven efficiencies as key factors.  
- Morgan Stanley also upgraded the stock to buy with a target price of $285.00, indicating confidence in its continued positive performance.

Tip Ranks

Analyst Lifts Assurant Price Target to $274 on Resilient Growth, Differentiated Device-Care Platform, and Margin Upside from AI Efficiencies

Assurant Inc. (AIZ) shares rose 4.17% to $252.72 on a strong trading day, marking a new 52-week high. This increase ended a two-day losing streak, while the S&P 500 and Dow Jones also saw gains. In contrast, competitors like Berkshire Hathaway Cl A and Cl B experienced slight declines, while Chubb Ltd. rose 1.29%. Trading volume for Assurant exceeded its 50-day average, indicating robust market activity.

MarketWatch Automated

S&P 500

Dow Jones Industrial Average

Berkshire Hathaway

Berkshire Hathaway B

Chubb

Factset Research

Assurant Inc. Stock Outperforms Competitors On Strong Trading Day

GBTC

GABF

EZBC

Financial stocks advanced on Thursday, with the NYSE Financial Index up 0.5% and the State Street Financial Select Sector SPDR ETF rising 0.6%. Bitcoin increased by 2.6% to $81,414, while 10-year US Treasury yields fell to 4.45%. Retail sales rose 0.5% in April, reflecting higher prices due to the war in Iran. Klarna shares surged 15% after reporting a narrower net loss and higher revenue. Interactive Brokers launched a new trading platform, and Blackstone's AirTrunk is seeking a $2.3 billion loan for facility development.

Fidelity

Grayscale Bitcoin Trust BTC - ETF

Gabelli Financial Services Opportunities ETF

Franklin Bitcoin ETF

ISHRS Us Brokers & Sec Exchg

Grayscale Solana Staking ETF

ARK 21Shares Bitcoin ETF

Financial Select Sector SPDR Fund

VanEck Bitcoin ETF

Blackrock Future Fin & Tech ETF

Invesco Dorsey Wright Financial Momentum ETF

ARK Fintech Innovation ETF

Fidelity Wise Origin Bitcoin Fund - ETF

Fidelity MSCI Financials Index

Invesco Galaxy Bitcoin ETF

WisdomTree Bitcoin Fund

Sector Update: Financial Stocks Advance Thursday Afternoon

Assurant, Inc.'s stock price target has been raised from $267.67 to $275.17, indicating a potential upside of approximately 13%. This estimate is based on forecasts from 6 analysts, with price targets ranging from $268 to $285 per share. The consensus rating remains a 'Buy' from 10 analysts, including 9 Buys and 1 Hold. This information is sourced from FactSet and does not constitute investment advice.

TradingView

Assurant, Inc. Stock 12‑Month Price Target Raised to $275.17, Implies 13% Upside

Truist Financial Corp reduced its stake in Assurant, Inc. by 58.3% in Q4, now holding 8,991 shares valued at $2.17 million. Other institutional investors have also adjusted their positions, with notable increases from Jones Financial and Goldman Sachs. Assurant's stock opened at $242.38, with a market cap of $12.01 billion. The company reported strong earnings, exceeding analyst expectations, and has received positive ratings from several analysts, with a consensus price target of $264.67.

Jones Soda Co.

Jefferies Financial

Love & Health Ltd

Nano Labs

Goldman Sachs

United Overseas Australia Ltd

Flagstar Financial

FLAGSTAR BANK NATIONAL ASSOCIATION 6% CNV 01/11/2051 USD

Ai Partners Financial Inc.

Empire State Realty OP - S250

Empire State Realty OP - S60

Wealth Management Inc

Genocea Biosciences

Change, Inc. (Japan)

UBS ETRACS BgCstMtCdy(CMCI)TtlRetETNSerB

United Internet AG

Penns Woods Bancorp

Kkr Real Estate Finance Trust

Webster Financial-Waterbury

GS Hldg R

FLAGSTAR BANK NATIONAL ASSOCIATION DEP SHS REP 1/40 INT FXD/FLTG RATE SER A

WEBSTER FINANCIAL CORP 5.25% NON CUM DEP SHS REP 1/1000 SER F

WEBSTER FINANCIAL CORP 6.5% DEP SHS REP 1/40TH NONCUM PFD SER G

Truist Financial Corp Reduces Stock Holdings in Assurant, Inc. $AIZ

Assurant(AIZ.US)

Assurant (NYSE:AIZ) Sets New 12-Month High - Should You Buy?